HRMY - Harmony gets FDA orphan drug status for Prader-Willi treatment
2024-02-20 15:12:56 ET
More on Harmony Biosciences
- Harmony Biosciences: 4 Problems With Investing (Rating Downgrade)
- Harmony Biosciences says Q4 preliminary net product revenue was about $168M
- Seeking Alpha’s Quant Rating on Harmony Biosciences
- Historical earnings data for Harmony Biosciences
- Financial information for Harmony Biosciences